亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Lung transplantation from donation after cardiocirculatory death: a systematic review and meta-analysis

医学 荟萃分析 科克伦图书馆 内科学 相对风险 置信区间 肺移植 移植 系统回顾 捐赠 预期寿命 重症监护医学 梅德林 人口 环境卫生 经济 法学 经济增长 政治学
作者
Dustin C. Krutsinger,Robert M. Reed,Amy Blevins,Varun Puri,Nilto C. De Oliveira,B. Zych,Servet Bölükbas,Dirk Van Raemdonck,Gregory I. Snell,Michael Eberlein
出处
期刊:Journal of Heart and Lung Transplantation [Elsevier BV]
卷期号:34 (5): 675-684 被引量:134
标识
DOI:10.1016/j.healun.2014.11.009
摘要

Background Lung transplantation (LTx) can extend life expectancy and enhance the quality of life for select patients with end-stage lung disease. In the setting of donor lung shortage and waiting list mortality, the interest in donation after cardiocirculatory death (DCD) is increasing. We performed a systematic review and meta-analysis to compare outcomes between DCD and conventional donation after brain death (DBD). Methods PubMed, CINAHL, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials, Scopus, Web of Science, and ClinicalTrials.gov were searched. We identified original research studies with 1-year post-transplant survival data involving >5 DCD transplants. We performed meta-analyses examining 1-year survival, primary graft dysfunction, and acute rejection after LTx. Results We identified 519 citations; 11 observational cohort studies met our inclusion criteria for systematic review, and 6 met our inclusion criteria for meta-analysis. There were no differences found in 1-year mortality after LTx between DCD and DBD cohorts in individual studies or in the meta-analysis (DCD [n = 271] vs DBD [n = 2,369], relative risk [RR] 0.88, 95% confidence interval [CI] 0.59–1.31, p = 0.52, I2 = 0%). There was also no difference between DCD and DBD in a pooled analysis of 5 studies reporting on primary graft dysfunction (RR 1.09, 95% CI 0.68–1.73, p = 0.7, I2 = 0%) and 4 studies reporting on acute rejection (RR 0.72, 95% CI 0.49–1.05, p = 0.09, I2 = 0%). Conclusions Survival after LTx from DCD is comparable to survival after LTx from DBD in observational cohort studies. DCD appears to be a safe and effective method to expand the donor pool. Lung transplantation (LTx) can extend life expectancy and enhance the quality of life for select patients with end-stage lung disease. In the setting of donor lung shortage and waiting list mortality, the interest in donation after cardiocirculatory death (DCD) is increasing. We performed a systematic review and meta-analysis to compare outcomes between DCD and conventional donation after brain death (DBD). PubMed, CINAHL, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials, Scopus, Web of Science, and ClinicalTrials.gov were searched. We identified original research studies with 1-year post-transplant survival data involving >5 DCD transplants. We performed meta-analyses examining 1-year survival, primary graft dysfunction, and acute rejection after LTx. We identified 519 citations; 11 observational cohort studies met our inclusion criteria for systematic review, and 6 met our inclusion criteria for meta-analysis. There were no differences found in 1-year mortality after LTx between DCD and DBD cohorts in individual studies or in the meta-analysis (DCD [n = 271] vs DBD [n = 2,369], relative risk [RR] 0.88, 95% confidence interval [CI] 0.59–1.31, p = 0.52, I2 = 0%). There was also no difference between DCD and DBD in a pooled analysis of 5 studies reporting on primary graft dysfunction (RR 1.09, 95% CI 0.68–1.73, p = 0.7, I2 = 0%) and 4 studies reporting on acute rejection (RR 0.72, 95% CI 0.49–1.05, p = 0.09, I2 = 0%). Survival after LTx from DCD is comparable to survival after LTx from DBD in observational cohort studies. DCD appears to be a safe and effective method to expand the donor pool.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_VZG7GZ的应助被白奕采纳,获得10
9秒前
水北完成签到,获得积分10
15秒前
狂野的御姐完成签到,获得积分10
17秒前
原子超人完成签到,获得积分10
21秒前
yinh完成签到 ,获得积分10
25秒前
支雨泽完成签到,获得积分10
26秒前
传统完成签到,获得积分10
31秒前
丸总发布了新的文献求助10
31秒前
31秒前
大力的美女完成签到,获得积分10
36秒前
科研通AI6.4的应助被u766482采纳,获得30
55秒前
BaconDan完成签到,获得积分10
1分钟前
碧蓝问玉完成签到,获得积分10
1分钟前
乐观的水瑶完成签到,获得积分10
1分钟前
NexusExplorer的应助被u516929采纳,获得30
1分钟前
1分钟前
2589发布了新的文献求助10
1分钟前
科研通AI6.2的应助被wxy小白鼠采纳,获得10
1分钟前
敏感天曼完成签到,获得积分10
2分钟前
ddl30完成签到,获得积分10
2分钟前
阔达的沛岚完成签到,获得积分10
2分钟前
丸总完成签到,获得积分10
2分钟前
江渕完成签到,获得积分10
2分钟前
2分钟前
CodeCraft的应助被丸总采纳,获得10
2分钟前
2分钟前
u583484发布了新的文献求助30
2分钟前
健忘香彤完成签到,获得积分10
2分钟前
u501249发布了新的文献求助30
2分钟前
畅快的夜云完成签到,获得积分10
2分钟前
2分钟前
u766482发布了新的文献求助30
2分钟前
3分钟前
u501249发布了新的文献求助30
3分钟前
小蘑菇的应助被2589采纳,获得10
3分钟前
wxy小白鼠发布了新的文献求助10
3分钟前
无奈小玉完成签到,获得积分10
3分钟前
3分钟前
甜美凝琴完成签到,获得积分10
3分钟前
u766482发布了新的文献求助30
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185196
求助须知:如何正确求助?哪些是违规求助? 9574060
关于积分的说明 21834179
捐赠科研通 7782698
什么是DOI,文献DOI怎么找? 3434531
关于科研通互助平台的介绍 2558786
邀请新用户注册赠送积分活动 2481218